U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07736911) titled 'Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.' on June 09.
Brief Summary: This study aims to evaluate the impact of a one-week discontinuation of long-acting glucagon-like peptide-1 receptor agonists (GLP-1 RAs) prior to Esophagogastroduodenoscopy on gastric preparation quality and the need for repeat esophagogastroduodenoscopy (EGD), in order to determine whether a one-week drug interruption constitutes an appropriate pre-procedural recommendation.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
GLP-1
Intervention:
DRUG: Stop for 1 week
Stop for 1 we...